Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Advanced Technique for Treating Esophageal Lesions

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

China Approves First Commercial Brain-Computer Interface

China has granted approval for the commercial sale of...

MiniMed 780G System Gains CE Mark...

MiniMed Group, a global provider of integrated insulin delivery...

SmartHeart, the Cardiac MR Suite by...

Philips received FDA 510(k) clearance for SmartHeart, which happens...
An increasingly popular technique for removing lesions associated with Barrett’s esophagus has been deemed a safe and effective treatment option in a study of more than 1,000 resections published this month in the European journal Endoscopy.¹ The five-year study performed by a team of experienced endoscopists, is the largest prospective series to date to examine the safety and efficacy of multiband mucosectomy (MBM), an endoscopic procedure that is a simple and fast treatment option for Barrett’s esophagus, a condition that can result from gastroesophageal reflux disease (GERD).

Dr. Jacques Bergman, MD PhD, Head of the Department of Endoscopy, lead author of the study and head of the esophageal research team at the Academic Medical Center in Amsterdam, Netherlands said, This study is an important milestone, both for the patients undergoing these procedures and for the physicians who perform them. With more than 1,000 resections and no perforations despite the absence of submucosal lifting, the conclusions of the five-year study support this technique as an effective option for treating these potentially cancerous lesions.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

China Approves First Commercial Brain-Computer Interface

China has granted approval for the commercial sale of...

MiniMed 780G System Gains CE Mark for Abbott Instinct Sensor

MiniMed Group, a global provider of integrated insulin delivery...

SmartHeart, the Cardiac MR Suite by Philips Gets Clearance

Philips received FDA 510(k) clearance for SmartHeart, which happens...

Medtronic Neurovascular Portfolio Strengthens with Scientia

Medtronic, on March 10, 2026, announced a definitive agreement...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »